Please use this identifier to cite or link to this item:
|Title:||Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence||Authors:||Sturm, Jonathan ;Golledge, J.;Clancy, P.;Maguire, J.;Lincz, L.;Koblar, Simon A ;McEvoy, M.;Attia, J.;Levi, C.R.;Almeida, O.P.;Yeap, B.B.;Flicker, L.;Norman, P.E.;Hankey, G.J.||Issue Date:||Apr-2014||Source:||Volume 45, Issue 4, pp. 1064 - 1068||Journal title:||Stroke||Abstract:||BACKGROUND AND PURPOSE: Studies in rodent models suggest that upregulating angiopoietin-1 (Angpt1) improves stroke outcomes. The aims of this study were to assess the association of plasma Angpt1 with stroke occurrence and outcome. METHODS: Plasma Angpt1 was measured in 336 patients who had experienced a recent stroke and 321 healthy controls with no stroke history. Patients with stroke (n=285) were reassessed at 3 months and plasma Angpt1 concentration on admission compared between those with severe and minor disability as assessed by the modified Rankin scale. In a separate cohort of 4032 community-acquired older men prospectively followed for a minimum of 6 years, the association of plasma Angpt1 with stroke incidence was examined. RESULTS: Median plasma Angpt1 was 3-fold lower in patients who had experienced a recent stroke (6.42, interquartile range, 4.26-9.53 compared with 17.36; interquartile range, 14.01-22.46 ng/mL; P<0.001) and remained associated with stroke after adjustment for other risk factors. Plasma Angpt1 concentrations on admission were lower in patients who had severe disability or died at 3 months (median, 5.52; interquartile range, 3.81-8.75 ng/mL for modified Rankin scale 3-6; n=91) compared with those with minor disability (median, 7.04; interquartile range, 4.75-9.92 ng/mL for modified Rankin scale 0-2; n=194), P=0.012, and remained negatively associated with severe disability or death after adjusting for other risk factors. Plasma Angpt1 was not predictive of stroke incidence in community-dwelling older men. CONCLUSIONS: Plasma Angpt1 concentrations are low after ischemic stroke particularly in patients with poor stroke outcomes at 3 months. Interventions effective at upregulating Angpt1 could potentially improve stroke outcomes.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1292||DOI:||10.1161/STROKEAHA.113.004339||Pubmed:||https://www.ncbi.nlm.nih.gov/pubmed/24569814||ISSN:||1524-4628||Publicaton type:||Journal Article||Keywords:||Neurology
|Appears in Collections:||Neurology|
Show full item record
checked on Feb 6, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.